UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5599) 5599
Book Chapter (170) 170
Book / eBook (32) 32
Newsletter (31) 31
Magazine Article (5) 5
Newspaper Article (5) 5
Reference (4) 4
Web Resource (4) 4
Dissertation (2) 2
Conference Proceeding (1) 1
Government Document (1) 1
Publication (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5014) 5014
science & technology (4265) 4265
life sciences & biomedicine (4085) 4085
female (2588) 2588
male (2480) 2480
oncology (2125) 2125
central nervous system (1925) 1925
middle aged (1704) 1704
adult (1631) 1631
aged (1264) 1264
central nervous system neoplasms - drug therapy (1252) 1252
cancer (1181) 1181
neurosciences & neurology (1075) 1075
chemotherapy (963) 963
treatment outcome (935) 935
clinical neurology (933) 933
child (895) 895
animals (867) 867
adolescent (830) 830
antineoplastic combined chemotherapy protocols - therapeutic use (792) 792
care and treatment (752) 752
hematology (719) 719
medicine & public health (684) 684
tumors (658) 658
nervous system (648) 648
prognosis (633) 633
central nervous system neoplasms - pathology (611) 611
child, preschool (598) 598
magnetic resonance imaging (571) 571
retrospective studies (563) 563
combined modality therapy (534) 534
antineoplastic agents - therapeutic use (514) 514
brain (514) 514
research (513) 513
patients (491) 491
radiotherapy (491) 491
pediatrics (476) 476
surgery (467) 467
central nervous system neoplasms - therapy (461) 461
abridged index medicus (436) 436
health aspects (436) 436
risk factors (435) 435
neurology (432) 432
neurosciences (427) 427
brain neoplasms - drug therapy (426) 426
brain tumors (417) 417
aged, 80 and over (413) 413
analysis (412) 412
infant (395) 395
medicine (380) 380
young adult (369) 369
lymphomas (365) 365
lymphoma (358) 358
methotrexate - administration & dosage (354) 354
diagnosis (353) 353
pharmacology & pharmacy (347) 347
follow-up studies (345) 345
central nervous system neoplasms - diagnosis (343) 343
metastasis (327) 327
central nervous system neoplasms - radiotherapy (319) 319
central nervous system neoplasms - mortality (317) 317
drug therapy (317) 317
neoplasms (317) 317
disease-free survival (313) 313
brain neoplasms - pathology (311) 311
central nervous system neoplasms - secondary (311) 311
lymphoma - drug therapy (309) 309
mice (302) 302
methotrexate (300) 300
survival analysis (298) 298
neoplasms - drug therapy (297) 297
gliomas (290) 290
survival rate (279) 279
children (277) 277
glioma (276) 276
radiation therapy (274) 274
brain cancer (269) 269
diseases (268) 268
recurrence (261) 261
glioblastoma (259) 259
cell line, tumor (255) 255
antineoplastic agents - adverse effects (251) 251
clinical trials (245) 245
antineoplastic combined chemotherapy protocols - adverse effects (242) 242
time factors (240) 240
survival (232) 232
hematology, oncology and palliative medicine (227) 227
central nervous system depressants (226) 226
general & internal medicine (225) 225
pathology (225) 225
neurosurgery (224) 224
drugs (221) 221
medicine, general & internal (219) 219
metastases (219) 219
methotrexate - therapeutic use (219) 219
antineoplastic agents - administration & dosage (218) 218
therapy (218) 218
development and progression (217) 217
dose-response relationship, drug (217) 217
radiology (216) 216
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (6) 6
Online Resources - Online (5) 5
St. Michael's Hospital - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Credit Valley Hospital - Reserve desk (1) 1
St. Michael's College (John M. Kelly) - Circulation Desk (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5711) 5711
Japanese (56) 56
French (35) 35
German (28) 28
Spanish (26) 26
Russian (16) 16
Chinese (14) 14
Polish (11) 11
Italian (10) 10
Portuguese (6) 6
Czech (4) 4
Hungarian (3) 3
Croatian (2) 2
Danish (2) 2
Dutch (2) 2
Norwegian (2) 2
Swedish (2) 2
Finnish (1) 1
Hebrew (1) 1
Korean (1) 1
Lithuanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2012, ISBN 9780791860038, viii, 99
Book
The New England journal of medicine, ISSN 1533-4406, 08/2017, Volume 377, Issue 9, pp. 829 - 838
Alectinib, a potent ALK tyrosine kinase inhibitor, was more effective and somewhat less toxic than crizotinib when used as primary therapy in patients with ALK -positive non... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Central Nervous System Neoplasms - secondary | Young Adult | Pyridines - adverse effects | Anaplastic Lymphoma Kinase | Antineoplastic Agents - adverse effects | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Receptor Protein-Tyrosine Kinases - analysis | Pyrazoles - adverse effects | Pyridines - therapeutic use | Crizotinib | Carbazoles - adverse effects | Kaplan-Meier Estimate | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Animals | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Intention to Treat Analysis | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Central Nervous System Neoplasms - drug therapy | Drugs | Care and treatment | Analysis | Comparative analysis | Lung cancer, Non-small cell | Health aspects | Systemic diseases | Toxicity | Lung cancer | Central nervous system | Non-small cell lung carcinoma | Oncology | Nervous system | Metastasis | Radiation therapy | Patients | Lymphoma | Cancer therapies | Survival | Mutation | Protein-tyrosine kinase | Drug dosages | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Journal of neuro-oncology, ISSN 0167-594X, 7/2006, Volume 78, Issue 3, pp. 255 - 260
Treatment options for patients with recurrent central nervous system (CNS) metastases are limited... 
metastases | Medicine & Public Health | leptomeninges | Oncology | methotrexate | brain | chemotherapy | central nervous system | Brain | Chemotherapy | Methotrexate | Central nervous system | Leptomeninges | Metastases | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Antimetabolites, Antineoplastic - administration & dosage | Central Nervous System Neoplasms - secondary | Dose-Response Relationship, Drug | Carcinoma, Squamous Cell - mortality | Adult | Female | Retrospective Studies | Carcinoma, Non-Small-Cell Lung - pathology | Neoplasms, Unknown Primary - drug therapy | Head and Neck Neoplasms - drug therapy | Treatment Outcome | Neoplasms, Unknown Primary - mortality | Breast Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Head and Neck Neoplasms - pathology | Methotrexate - adverse effects | Carcinoma, Squamous Cell - drug therapy | Breast Neoplasms - pathology | Antimetabolites, Antineoplastic - adverse effects | Survival Analysis | Breast Neoplasms - mortality | Methotrexate - administration & dosage | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Head and Neck Neoplasms - mortality | Infusions, Intravenous | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Neoplasms, Unknown Primary - pathology | Metastasis | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 05/2008, Volume 26, Issue 15, pp. 2442 - 2449
Journal Article
Journal Article
Journal Article
Journal Article
Journal of neuro-oncology, ISSN 0167-594X, 3/2012, Volume 107, Issue 1, pp. 191 - 196
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 07/2010, Volume 77, Issue 3, pp. 655 - 661
... standard of care, WBRT, is appropriate as the primary treatment of all patients with BMs instead of reserving WBRT for later salvage therapy, as needed... 
Radiology | Hematology, Oncology and Palliative Medicine | radiotherapy | Brain metastases | prognosis | stereotactic radiosurgery | Oncology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Carcinoma, Non-Small-Cell Lung - radiotherapy | Gastrointestinal Neoplasms | Prognosis | Age Factors | Humans | Middle Aged | Lung Neoplasms | Small Cell Lung Carcinoma - drug therapy | Small Cell Lung Carcinoma - secondary | Brain Neoplasms - secondary | Carcinoma, Non-Small-Cell Lung - secondary | Karnofsky Performance Status | Small Cell Lung Carcinoma - radiotherapy | Retrospective Studies | Brain Neoplasms - radiotherapy | Carcinoma, Renal Cell - drug therapy | Kidney Neoplasms | Brain Neoplasms - diagnosis | Melanoma - radiotherapy | Treatment Outcome | Brain Neoplasms - drug therapy | Melanoma - secondary | Carcinoma, Renal Cell - radiotherapy | Analysis of Variance | Carcinoma, Renal Cell - secondary | Melanoma - drug therapy | Skin Neoplasms | Selection Bias | Aged | Combined Modality Therapy - methods | Carcinoma, Non-Small-Cell Lung - drug therapy | Care and treatment | Metastasis | Patient outcomes | Analysis | Index Medicus | SURGERY | METASTASES | NERVOUS SYSTEM | CENTRAL NERVOUS SYSTEM | MEDICINE | NUCLEAR MEDICINE | ORGANS | THERAPY | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | BODY | BRAIN | RADIOLOGY
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2001, Volume 19, Issue 3, pp. 742 - 749
...) days -6 through -4, and cyclophosphamide 60 mg/kg/d days -3 and -2. intravenous clonazepam 2 mg/d was given prophylactically from the day before initiation of busulfan therapy to the day after completion of busulfan therapy... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Thiotepa - administration & dosage | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Male | Eye Neoplasms - therapy | Lymphoma, Large-Cell, Immunoblastic - therapy | Busulfan - administration & dosage | Feasibility Studies | Dose-Response Relationship, Drug | Eye Neoplasms - drug therapy | Lymphoma, Large B-Cell, Diffuse - therapy | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Lymphoma, B-Cell - drug therapy | Lymphoma, Non-Hodgkin - drug therapy | Lymphoma, Large B-Cell, Diffuse - drug therapy | Neoplasm Recurrence, Local - therapy | Central Nervous System Neoplasms - therapy | Etoposide - administration & dosage | Combined Modality Therapy | Cytarabine - administration & dosage | Disease-Free Survival | Lymphoma, T-Cell - drug therapy | Lymphoma, Non-Hodgkin - therapy | Lymphoma, T-Cell - therapy | Lymphoma, Large-Cell, Immunoblastic - drug therapy | Methotrexate - administration & dosage | Nervous System Diseases - chemically induced | Central Nervous System Neoplasms - drug therapy | Index Medicus
Journal Article
01/2011, Tumors of the central nervous system, ISBN 9400703430, Volume Part 1, 405
...) in the brain are presented in this book. The importance of personalised medicine and clinical validation for targeted therapy are also discussed. 
Gliomas | Brain | Spine | Acoustic neuroma | Meningioma | Pituitary gland | Pineal gland | Tumors in children | Central nervous system | Tumors
eBook
Clinical Cancer Research, ISSN 1078-0432, 01/2010, Volume 16, Issue 1, pp. 269 - 278
Journal Article